Elevance Health, Inc. (NYSE:ELV) Receives $565.82 Consensus Price Target from Brokerages

Elevance Health, Inc. (NYSE:ELV – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twelve ratings firms that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month price […]

Leave a Reply

Your email address will not be published.

Previous post Criteo S.A. (NASDAQ:CRTO) Receives $35.67 Average PT from Analysts
Next post Marks and Spencer Group plc (LON:MKS) Receives GBX 242.86 Consensus Price Target from Brokerages